Literature DB >> 26643896

MTUS1 and its targeting miRNAs in colorectal carcinoma: significant associations.

Onder Ozcan1, Murat Kara2, Onder Yumrutas3, Esra Bozgeyik4, Ibrahim Bozgeyik3, Ozgur Ilhan Celik5.   

Abstract

Deregulated microRNA (miRNA) expression has been shown to be involved in the pathogenesis of several types of cancers including colorectal cancer (CRC). Thus, determining miRNA targets of genes that play critical role in the malignant transformation is very important. Here, expression levels of tumor suppressor microtubule-associated tumor suppressor 1 (MTUS1) and its regulatory miRNAs were reported. Predicted and validated targets of MTUS1 gene was determined by a computational approach. Expressions of MTUS1 and miRNAs were determined by using 96.96 Dynamic Array™ integrated fluidic circuit (Fluidigm). As a result, MTUS1 levels were found to be diminished in formalin-fixed, paraffin-embedded (FFPE) tissue samples of CRC patients compared to controls. Also, several of MTUS1 targeting miRNAs were found to be upregulated in CRC samples (miR-373-3p, 183-5p, 142-5p, 200c-3p, 19a-3p, -20a-5p, -181a-5p, -184, -181d-5p, -372-3p, 27b-3p, 98-5p, -let-7i-5p, -let-7d-5p, -let-7g-5p, -let-7b-5p, and -let-7c-5p). Of these miRNAs, miR-135b-5p, -373-3p, 183-5p, 142-5p, 200c-3p, 19a-3p showed marked expression levels. In contrast, expression levels of let-7a-5p, 7e-5p, 7f-5p, hsa-miR-125a-5p, and 125b-5p were found to be downregulated in CRC tissues. Accordingly, some of the overexpressed miRNAs especially the miR-135b-5p, -373-3p, 183-5p, 142-5p, 200c-3p, and 19a-3p may play key roles in CRC pathophysiology through MTUS1. In contrast, let-7a-5p, 7e-5p, 7f-5p, miR-125a-5p, and 125b-5p may play important roles in CRC carcinogenesis independent from the MTUS1. In conclusion, MTUS1 targeting miRNAs may play key roles in the development of CRC by downregulating tumor suppressor MTUS1.

Entities:  

Keywords:  Colorectal cancer; MTUS1; miR-135b-5p; miR-183-5p; miR-373-3p; miRNA

Mesh:

Substances:

Year:  2015        PMID: 26643896     DOI: 10.1007/s13277-015-4550-4

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  49 in total

1.  Trans-inactivation of receptor tyrosine kinases by novel angiotensin II AT2 receptor-interacting protein, ATIP.

Authors:  Sandrine Nouet; Nathalie Amzallag; Jian-Mei Li; Simon Louis; Isabell Seitz; Tai-Xing Cui; Anne-Marie Alleaume; Mélanie Di Benedetto; Christine Boden; Maryline Masson; A Donny Strosberg; Masatsugu Horiuchi; Pierre-Olivier Couraud; Clara Nahmias
Journal:  J Biol Chem       Date:  2004-04-29       Impact factor: 5.157

2.  Prediction of both conserved and nonconserved microRNA targets in animals.

Authors:  Xiaowei Wang; Issam M El Naqa
Journal:  Bioinformatics       Date:  2007-11-29       Impact factor: 6.937

3.  MicroRNA and targeted mRNA expression profiling analysis in human colorectal adenomas and adenocarcinomas.

Authors:  Charles-Henry Gattolliat; Arnaud Uguen; Marine Pesson; Kilian Trillet; Brigitte Simon; Laurent Doucet; Michel Robaszkiewicz; Laurent Corcos
Journal:  Eur J Cancer       Date:  2015-01-10       Impact factor: 9.162

4.  Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection.

Authors:  X Zhang; Z Yan; J Zhang; L Gong; W Li; J Cui; Y Liu; Z Gao; J Li; L Shen; Y Lu
Journal:  Ann Oncol       Date:  2011-02-22       Impact factor: 32.976

5.  Differential expressions of cancer-associated genes and their regulatory miRNAs in colorectal carcinoma.

Authors:  Murat Kara; Onder Yumrutas; Onder Ozcan; Ozgur Ilhan Celik; Esra Bozgeyik; Ibrahim Bozgeyik; Sener Tasdemir
Journal:  Gene       Date:  2015-04-27       Impact factor: 3.688

6.  Five miRNAs as novel diagnostic biomarker candidates for primary nasopharyngeal carcinoma.

Authors:  Jin-Feng Tang; Zhong-Hua Yu; Tie Liu; Zi-Ying Lin; Ya-Hong Wang; La-Wei Yang; Hui-Juan He; Jun Cao; Hai-Li Huang; Gang Liu
Journal:  Asian Pac J Cancer Prev       Date:  2014

7.  starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data.

Authors:  Jian-Hua Yang; Jun-Hao Li; Peng Shao; Hui Zhou; Yue-Qin Chen; Liang-Hu Qu
Journal:  Nucleic Acids Res       Date:  2010-10-30       Impact factor: 16.971

8.  The microRNA.org resource: targets and expression.

Authors:  Doron Betel; Manda Wilson; Aaron Gabow; Debora S Marks; Chris Sander
Journal:  Nucleic Acids Res       Date:  2007-12-23       Impact factor: 16.971

9.  starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data.

Authors:  Jun-Hao Li; Shun Liu; Hui Zhou; Liang-Hu Qu; Jian-Hua Yang
Journal:  Nucleic Acids Res       Date:  2013-12-01       Impact factor: 16.971

10.  A ten-microRNA signature identified from a genome-wide microRNA expression profiling in human epithelial ovarian cancer.

Authors:  Lin Wang; Miao-Jun Zhu; Ai-Min Ren; Hong-Fei Wu; Wu-Mei Han; Ruo-Ying Tan; Rui-Qin Tu
Journal:  PLoS One       Date:  2014-05-09       Impact factor: 3.240

View more
  19 in total

1.  [Specific microRNA expression profiles of lung adenocarcinoma in Xuanwei region and bioinformatic analysis for predicting their target genes and related signaling pathways].

Authors:  Shuai Chen; Yong-Chun Zhou; Ying Chen; Xiao-Bo Chen; Guang-Jian Li; Jia-Peng Yang; Yu-Jie Lei; Guang-Qiang Zhao; Qiu-Bo Huang; Chang-Shao Yang; Ya-Xi DU; Yun-Chao Huang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-02-20

2.  The Construction and Analysis of ceRNA Network and Patterns of Immune Infiltration in Colon Adenocarcinoma Metastasis.

Authors:  Zhengyan Chang; Runzhi Huang; Wanting Fu; Jiehan Li; Guo Ji; Jinglei Huang; Weijun Shi; Huabin Yin; Weifeng Wang; Tong Meng; Zongqiang Huang; Qing Wei; Huanlong Qin
Journal:  Front Cell Dev Biol       Date:  2020-08-04

3.  Loss of MTUS1 Expression Is Associated With Poor Prognosis in Patients With Gallbladder Carcinoma.

Authors:  Jongmin Sim; Yeseul Kim; Hyungsung Kim; Seongsik Bang; Seungyun Jee; Seongun Park; Su-Jin Shin; Kiseok Jang
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

4.  Let-7c inhibits cholangiocarcinoma growth but promotes tumor cell invasion and growth at extrahepatic sites.

Authors:  Yu Xie; Hang Zhang; Xing-Jun Guo; Ye-Chen Feng; Rui-Zhi He; Xu Li; Shuo Yu; Yan Zhao; Ming Shen; Feng Zhu; Xin Wang; Min Wang; Asha Balakrishnan; Michael Ott; Feng Peng; Ren-Yi Qin
Journal:  Cell Death Dis       Date:  2018-02-14       Impact factor: 8.469

5.  MicroRNAs as outcome predictors in patients with metastatic colorectal cancer treated with bevacizumab in combination with FOLFOX.

Authors:  I Kiss; J Mlčochová; K Součková; P Fabian; A Poprach; J Halamkova; M Svoboda; R Vyzula; O Slaby
Journal:  Oncol Lett       Date:  2017-05-26       Impact factor: 2.967

6.  Clinically Significant Dysregulation of hsa-miR-30d-5p and hsa-let-7b Expression in Patients with Surgically Resected Non-Small Cell Lung Cancer.

Authors:  Sayed Mostafa Hosseini; Bahram Mohammad Soltani; Mahmoud Tavallaei; Seyed Javad Mowla; Elham Tafsiri; Abouzar Bagheri; Hamid Reza Khorram Khorshid
Journal:  Avicenna J Med Biotechnol       Date:  2018 Apr-Jun

Review 7.  Microtubule-Associated Protein ATIP3, an Emerging Target for Personalized Medicine in Breast Cancer.

Authors:  Maria M Haykal; Sylvie Rodrigues-Ferreira; Clara Nahmias
Journal:  Cells       Date:  2021-05-01       Impact factor: 6.600

8.  Peripheral leukocyte microRNAs as novel biomarkers for COPD.

Authors:  Ruiying Wang; Jianying Xu; Hu Liu; Zhiping Zhao
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-04-06

9.  Overexpression of miR-135b-5p promotes unfavorable clinical characteristics and poor prognosis via the repression of SFRP4 in pancreatic cancer.

Authors:  Xu Han; Hexige Saiyin; Junjie Zhao; Yuan Fang; Yefei Rong; Chenye Shi; Wenhui Lou; Tiantao Kuang
Journal:  Oncotarget       Date:  2017-07-10

10.  miRNAs-Based Molecular Signature for KRAS Mutated and Wild Type Colorectal Cancer: An Explorative Study.

Authors:  Elena Milanesi; Maria Dobre; Alina Ioana Bucuroiu; Vlad Herlea; Teodora Ecaterina Manuc; Alessandro Salvi; Giuseppina De Petro; Mircea Manuc; Gabriel Becheanu
Journal:  J Immunol Res       Date:  2020-06-23       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.